Pre-earnings options volume in VistaGen Therapeutics is 2.6x normal with calls leading puts 8:7. Implied volatility suggests the market is anticipating a move near 19.2%, or $1.49, after results are released. Median move over the past eight quarters is 4.9%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on VTGN:
- Vistagen reports positive Phase 3 trial results of Fasedienol in SAD
- Vistagen up 29% as Commodore Capital increases position by $18M
- Biotech Alert: Searches spiking for these stocks today
- VistaGen Therapeutics trading resumes
- VistaGen Therapeutics trading halted, volatility trading pause
Questions or Comments about the article? Write to editor@tipranks.com